EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fluorodeoxyglucose PET in Radiation Oncology Planning

Ria Brown, Jay Garlapati, Soumon Rudra, Amol Madan Takalkar

PET Clinics · 2027-01 · 22 (1) · 209-224

DOI: 10.1016/j.cpet.2026.06.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PET Clinics, 2027-01. Verfasst von Ria Brown und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Radiotherapy Planning, Computer-Assisted, Radiopharmaceuticals, Positron-Emission Tomography. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluorodeoxyglucose (FDG) PET is a critical functional imaging modality in modern radiation therapy, enabling improved tumor detection, target delineation, and treatment assessment. This review highlights FDG-PET's role in radiotherapy planning, including integration through image registration, PET/computed tomography simulation, and incorporation of quantitative metrics for segmentation and dose optimization. Emerging applications such as adaptive radiotherapy and dose painting are discussed, along with using FDG-PET to assess treatment response. FDG-PET also provides insight into radiation-induced normal tissue changes and prior treatment fields. Collectively, FDG-PET enhances precision in radiotherapy planning and supports more personalized, response-adaptive treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Radiotherapy Planning, Computer-AssistedRadiopharmaceuticalsPositron-Emission TomographyNeoplasmsRadiation OncologyHumansPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

Adaptive radiotherapyFDG-PET/CTImage registrationRadiotherapy planningTarget delineation

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiation and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: amol.madan.takalkar@emory.edu.

Zitieren

APA

Brown, R., Garlapati, J., Rudra, S., & Takalkar, A. M. (2027). Fluorodeoxyglucose PET in Radiation Oncology Planning. PET Clinics, 22(1), 209-224. https://doi.org/10.1016/j.cpet.2026.06.013

Vancouver

Brown R, Garlapati J, Rudra S, Takalkar AM. Fluorodeoxyglucose PET in Radiation Oncology Planning. PET Clinics. 2027;22(1):209-224. doi:10.1016/j.cpet.2026.06.013

BibTeX
@article{Brown2027,
  author = {Brown, Ria and Garlapati, Jay and Rudra, Soumon and Takalkar, Amol Madan},
  title = {Fluorodeoxyglucose PET in Radiation Oncology Planning},
  journal = {PET Clinics},
  year = {2027},
  volume = {22},
  number = {1},
  pages = {209--224},
  doi = {10.1016/j.cpet.2026.06.013}
}
Kostenlos starten →